Novartis AG vs Vital Farms Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vital Farms Inc trades at $13.16 (market cap $590.45M). The key difference: Novartis AG is far larger — about 491.6× Vital Farms Inc's market cap, and Novartis AG pays a 3.17% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| NVS | VITL | |
|---|---|---|
Market Cap | $290.25B | $590.45M |
Sector | Health | Consumer Staples |
52-Week High | $168.62 | $52.41 |
52-Week Low | $113.50 | $8.28 |
Enterprise Value | $330.27B | $593.26M |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →